Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dougherty, T., and White, A. Influence of hormones on lymphoid tissue structure and function. Role of pituitary adrenotrophic hromone in regulation of lymphocytes and other cellular elements of the blood. Endocrinology 35: 1, 1944.
Dougherty, T., and White, A. Evaluation of alterations produced in lymphoid tissue by pituitary adrenal cortical secretion. J Lab Clin Med 32: 584, 1947.
Makman, M., Dvorkin, B., and White, A. Influence of cortisol on the utilization of precursors of nucleic acids and protein by lymphoid cells in vitro. J Biol Chem 243: 1485, 1968.
Werthamer, S., Hicks, C., and Arnaral, L. Protein synthesis in human leukocytes and lymphocytes: 1. Effect of steroid and sterols. Blood 34: 348, 1969.
Rosenthal, M., Saunders, R., Schwartz, L., et al. The use of adrenocorticotrophic hormone and cortisone in the treatment of leukemia and leukosarcoma. Blood 6: 804, 1951.
Southam, C. A study of the natural history of acute leukemia. Cancer 4: 39, 1951.
Bernard, J., and Deltour, G. Les nouveaux traitements des leucoses: TEPA-GT 41 (Myleran)-6-mercaptopurine-mercaptoethylamine: doses tres fortes de cortisone. Sem hop de Paris 29: 3430, 1953.
Fessas, P., Wintrobe, M., Thompson, R., et al. Treatment of acute leukemia with cortisone and corticotropin. AMA Arch Intern Med 94: 384, 1954.
Hill, J., Marshall, G., and Falco, D. Massive prednisone and prednisolone therapy in leukemia and lymphomas in adults. J Amer Geriat Soc 4: 627, 1956.
Hyman, C., and Sturgeon, P. Prednisone therapy of acute lymphatic leukemia in children. Cancer 9: 956, 1956.
Ranney, H., and Gellhorn, A. The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. Amer J Med 22: 405, 1957.
Kofman, S., Garvin, J., Nagamani, D., et al. Treatment of cerebral metastases from breast carcinoma with prednisolone. JAMA 163: 1473, 1957.
Pierce, M. The acute leukemias of childhood. Pediat Clin N Amer 4: 497, 1957.
Kofman, S., Nagamani, D., Buenger, R., et al. The use of prednisolone in the treatment of disseminated breast carcinoma. Cancer 11: 226, 1958.
Granville, N., Rubio, F., Unugur, A., et al. Treatment of acute leukemia in adults with massive doses of prednisone and prednisolone. New Eng J Med 259: 207, 1958.
Bouroncle, the effect leukemia.Prednisone therapy of advanced mammary cancer. 93, 1959.
Lemon, H. Cancer 12: B., Doan, C., and Wiseman, B. Evaluation of of massive prednisolone therapy in acute Acta Haemat 22: 201, 1959.
Hyman, C., Borda, E., Brubaker, C., et al. Prednisone in childhood leukemia. Comparison of interrupted with continuous therapy. Pediatrics 24: 1005, 1959.
Wolf, J., Spear, P., Yessner, Y., et al. The sex hormones and cortisone in the treatment of inoperable bronchogenic carcinoma. In “Biological Activities of Steroids in Relation to Cancer”, (Pincus, G., and Vollmer, E., eds.), Academic Press, New York, pp 413–426, 1960.
Freymann, J., Vander, J., Burrell, S., et al. Corticosteroid therapy of chronic lymphocytic leukemia: a study of erythrocyte survival and leukocyte dynamics. Acta Un Int Cancr 16: 849, 1960.
Freymann, J., Vander, J., Marier, E., et al. Corticosteroid therapy of chronic lymphocytic leukemia. Brit J Haemat 6: 303, 1960.
Shaw, R., Boggs, D., Silberman, H., et al. A study of prednisone therapy in chronic lymphocytic leukemia. Blood 17: 182, 1961.
Hume, R., Goldberg, A., and Garvic, D. Steroid therapy in multiple myeloma. Soct Med J 6: 189, 1961.
Galton, D., Whiltshaw, E., Szur, L., et al. The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukemia. Brit J Haemat 7: 73, 1961.
Boggs, D., Wintrobe, M., and Cartwright, G. The acute leukemias. Medicine 41: 163, 1962.
Shanbrom, E., and Miller, S. Critical evaluation of massive steroid therapy of acute leukemia. New Eng J Med 266: 1354, 1962.
Bernard, J., Boiron, M., Weil, M., et al. Etude de la remission complete des leucemies aigues. Nouv Rev France Hemat 2: 195, 1962.
Kyle, R., McFarland, C., and Dameshek, W. Large doses of prednisone and prednisolone in the treatment of malignant lymphoproliferative disorders. Ann Intern Med 57: 717, 1962.
Mass, R. A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma. Cancer Chemother Rep 16: 257, 1962.
Kofman, S., Perlia, C., Boesen, E., et al. The role of corticosteroids in the treatment of malignant lymphomas. Cancer 15: 338, 1962.
Freireich, E., Gehan, E., Frei, E., et al. The effect of 6-mercaptopurine on the duration of steroid-induced remissions in acute leukemia: a model for evaluation of other potentially useful therapy. Blood 21: 699, 1963.
Colsky, J., Shnider, B., Jones, R., et al. A comparative study of 9a-bromo-11–8-ketoprogesterone and prednisolone in the treatment of advanced carcinoma of the female breast. Cancer 16: 502, 1963.
Berkhirser, S. Epithelial proliferation of the lung associated with cortisone administration. Cancer 16: 1354, 1963.
Stoll, B. Corticosteroids in therapy of advanced mammary cancer. Brit Med J 5351: 210, 1963.
Roath, S., Israels, M., and Wilkinson, J. The acute leukemias: a study of 580 patients. Quarterly J Med 33: 257, 1964.
Freckman, H., Fry, H., Mendez, F., et al. Chlorambucilprednisolone therapy for disseminated breast carcinoma. JAMA 189: 23, 1964.
Burningham, R., Restrepo, A., Pugh, R., et al. Weekly high-dose glucocorticosteroid treatment of lymphocytic leukemias and lymphomas. New Eng J Med 270: 1160, 1964.
Nissen-Meyer, R. Endocrine treatment of breast cancer. Acta Un Int Cancr 20: 531, 1964.
Vietti, T., Sullivan, M., Berry, D., et al. The response of acute childhood leukemia to an initial and a second course of prednisone. J Pediat 66: 18, 1965.
Ruderman, N., and Hall, T. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 18: 298, 1965.
Mannheimer, I. Hypercalcemia of breast cancer. Management with corticosteroids. Cancer 18: 679, 1965.
Berlin, N., Andervont, H., Shimkin, M., et al. Breast cancer. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med 63: 321, 1965.
Working party on the evaluation of different methods of therapy in leukemia. Brit Med J 1: 1383, 1966.
Hall, T., Choi, 0., Abadi, A., et al. High-dose corticoid therapy in Hodgkin’s disease and other lymphomas. Ann Intern Med 66: 1144, 1967.
Wolff, J., Brubaker, C., Murphy, M., et al. Prednisone therapy of acute childhood leukemia: prognosis and duration of response in 330 treated patients. J Pediat 70: 626, 1967.
Salmon, S., Shadduck, R., and Schilling, A. Intermittent high-dose prednisone (NSC 10023) therapy for multiple myeloma. Cancer Chemother Rep 51: 179, 1967.
Moore, F., Woodrow, S., Aliapoulions, M., et al. Medical progress. Carcinoma of the breast. A decade of new results with old concepts. New Eng J Med 277: 460, 1967.
Leikin, S., Brubaker, C., Hartmann, J., et al. Varying prednisone dosage in remission induction of previously untreated childhood leukemia. Cancer 21: 346, 1968.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1970 IFI/Plenum · New York-Washington-London
About this chapter
Cite this chapter
Livingston, R.B., Carter, S.K. (1970). Prednisone and Prednisolone. In: Single Agents in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1378-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1378-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1380-9
Online ISBN: 978-1-4684-1378-6
eBook Packages: Springer Book Archive